Efficacy and Safety of Rituximab in Treating Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd): A Systematic Review and Meta-Analysis

Efficacy and Safety of Rituximab in Treating Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd): A Systematic Review and Meta-Analysis Publisher Pubmed

Mirmosayyeb O^{1, 2, 3} ; Shaygannejad V^{1, 2} ; Barzegar M^{1, 2} ; Nehzat N² ; Ghajarzadeh M³

Show Affiliations

1. Department of Neurology, School of medicine, Isfahan University of medical sciences, Isfahan, Iran
2. Isfahan Neurosciences Research Center, Isfahan University of medical sciences, Isfahan, Iran
3. Universal Council of Epidemiology (UCE), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran

Source: Autoimmunity Reviews Published:2021

Abstract

[No abstract available]

Related Docs

1. Adverse Drug Reactions of Rituximab in Patients Suffering From Autoimmune Neurological Diseases, DARU# Journal of Pharmaceutical Sciences (2022)

2. Efficacy and Safety of Rituximab in Treating Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Autoimmunity Reviews (2020)

Experts (# of related papers)

View all Related Experts

Amirreza Azimi (1)

Kheirollah Gholami (1)

Style	Citing Format
MLA	Mirmosayyeb O, et al.. "Efficacy and Safety of Rituximab in Treating Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd): A Systematic Review and Meta-Analysis." Autoimmunity Reviews, vol. 20, no. 2, 2021, pp. -.
APA	Mirmosayyeb O, Shaygannejad V, Barzegar M, Nehzat N, Ghajarzadeh M (2021). Efficacy and Safety of Rituximab in Treating Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd): A Systematic Review and Meta-Analysis. Autoimmunity Reviews, 20(2), -.
Chicago	Mirmosayyeb O, Shaygannejad V, Barzegar M, Nehzat N, Ghajarzadeh M. "Efficacy and Safety of Rituximab in Treating Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd): A Systematic Review and Meta-Analysis." Autoimmunity Reviews 20, no. 2 (2021): -.
Harvard	Mirmosayyeb O et al. (2021) 'Efficacy and Safety of Rituximab in Treating Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd): A Systematic Review and Meta-Analysis', Autoimmunity Reviews, 20(2), pp. -.
Vancouver	Mirmosayyeb O, Shaygannejad V, Barzegar M, Nehzat N, Ghajarzadeh M. Efficacy and Safety of Rituximab in Treating Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd): A Systematic Review and Meta-Analysis. Autoimmunity Reviews. 2021;20(2):-.
BibTex	@article{ author = {Mirmosayyeb O and Shaygannejad V and Barzegar M and Nehzat N and Ghajarzadeh M}, title = {Efficacy and Safety of Rituximab in Treating Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd): A Systematic Review and Meta-Analysis}, journal = {Autoimmunity Reviews}, volume = {20}, number = {2}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Mirmosayyeb O AU - Shaygannejad V AU - Barzegar M AU - Nehzat N AU - Ghajarzadeh M TI - Efficacy and Safety of Rituximab in Treating Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd): A Systematic Review and Meta-Analysis JO - Autoimmunity Reviews VL - 20 IS - 2 SP - EP - PY - 2021 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract